Endometriosis affects 190 million women and girls. Our team is developing better diagnostics and treatments for this understudied gynecologic disorder.
Endometriosis, a debilitating condition affecting approximately 190 million women and girls during their reproductive years, is marked by the abnormal growth of endometrial-like tissue outside the uterus, leading to acute pelvic pain and long-term fertility issues. Currently, diagnosing the disease requires surgery and treatment often involves hormonal suppression with unwanted side effects. In advanced stages, lesions can spread to multiple organs, making them difficult to access and often necessitating multiple surgeries. We’re developing a multi-faceted nanoparticle technology to comprehensively diagnose and treat endometriosis using a physiologically relevant model that allows for more accurate targeting and permanent eradication of lesions.